CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis

Journal of Neuroimmunology

Volumn 149, Issue 1-2, 2004, Pages 182-186

  Narikawa, Koichi ^a   Misu, Tatsuro ^a   Fujihara, Kazuo ^a   Nakashima, Ichiro ^a   Sato, Shigeru ^b   Itoyama, Yasuto ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOHNAN HOSPITAL   (Japan)

Author keywords

Chemokine; Multiple sclerosis; Relapsing neuromyelitis optica

Indexed keywords

CHEMOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECURRENT DISEASE;

AGE OF ONSET; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; STATISTICS, NONPARAMETRIC;

EID: 1542395857     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.12.010     Document Type: Article

References (16)

1. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U. S. A. 96:1999;6873-6878.
2. Franciotta D., Martino G., Zardini E., Furlan R., Bergamaschi R., Andreoni L., Cosi V. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J. Neuroimmunol. 115:2001;192-198.
3. Lucchinetti C.F., Mandler R.N., McGavern D., Bruck W., Gleich G., Ransohoff R.M., Trebst C., Weinshenker B., Wingerchuk D., Parisi J.E., Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 125:2002;1450-1461.
4. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. New Engl. J. Med. 338:1998;436-445.
5. Mahad D.J., Ransohoff R.M. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin. Immunol. 15:2003;23-32.
6. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50:2001;121-127.
7. Misu T., Onodera H., Fujihara K., Matsushima K., Yoshie O., Okita N., Takase S., Itoyama Y. Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling. J. Neuroimmunol. 114:2001;207-212.
8. Misu T., Fujihara K., Nakashima I., Miyazawa I., Okita N., Takase S., Itoyama Y. Pure optic-spinal form of multiple sclerosis in Japan. Brain. 125:2002;2460-2468.
9. Nakashima I., Fujihara K., Fujimori J., Narikawa K., Misu T., Itoyama Y. Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis optica. Neurology. 62:2004;144-146.
10. O'Riordan J.I., Gallagher H.L., Thompson A.J., Howard R.S., Kingsley D.P., Thompson E.J., McDonald W.I., Miller D.H. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J. Neurol. Neurosurg. Psychiatry. 60:1996;382-387.
11. Sallusto F., Lanzavecchia A., Mackay C.R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today. 19:1998;568-574.
12. Scarpini E., Galimberti D., Baron P., Clerici R., Ronzoni M., Conti G., Scarlato G. IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease. J. Neurol. Sci. 195:2002;41-46.
13. Sindern E., Niederkinkhaus Y., Henschel M., Ossege L.M., Patzold T., Malin J.P. Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis. Acta Neurol. Scand. 104:2001;88-91.
14. Sørensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., Qin S., Rottman J., Sellebjerg F., Strieter R.M., Frederiksen J.L., Ransohoff R.M. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:1999;807-815.
15. Sørensen T.L., Sellebjerg F., Jensen C.V., Strieter R.M., Ransohoff R.M. Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis. Eur. J. Neurol. 8:2001;665-672.
16. Wingerchuk D.M., Hogancamp W.F., O'Brien P.C., Weinshenker B.G. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 53:1999;1107-1114.